Takeda to divest select assets in China to Hasten Biopharmaceutic for $322 mn
The portfolio to be divested to Hasten includes cardiovascular and metabolism products sold in mainland China
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
pharma deals
Three big-ticket deals contributed 69 per cent of total deal value in November 2020
The healthcare industry reported 91 VC deals worth $3.3 billion in November 2020
Healthcare industry reports 86 deals worth $25.5 billion in Oct 2020
Three major deals contributes 72 per cent of total deal value
Three major deals contributed 74 per cent of deal value in August 2020
Deal value in the M&A market reported a surge in this month, as per a GlobalData report
Healthcare industry reports 95 deals worth $4.9 billion in July 2020
Deal value decreased by 40 per cent in July 2020, compared to June 2020, informs a report from GlobalData
Dr Reddy’s Laboratories completes acquisition of Wockhardt’s select business divisions
The acquired divisions comprise a portfolio of 62 brands in multiple therapy areas such as respiratory, neurology, VMS,…
Cipla acquires stake in GoApptiv
The acquisition of 21.85 per cent stake on a fully diluted basis will be completed in two stages
AstraZeneca approached Gilead Sciences for a merger: Bloomberg report
Reportedly, AstraZeneca contacted Gilead last month but the latter is not interested in merging or selling to another big pharma…
Boehringer Ingelheim acquires Northern Biologics’ preclinical cancer antibody pipeline
The acquisition provides assets targeting tumour stroma and myeloid cells
Pharma industry witnesses 50 deals worth $3 billion in April 2020
Three major deals contributed 72 per cent of deal value in April 2020